Revenio Group Corporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Revenio Group Corporation
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for detecting diseases of significance to public health. Its ophthalmic diagnostic solutions includes intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, USA, and Others.
/ 
Frequently asked questions
To buy Revenio Group Corporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Revenio Group Corporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Revenio Group Corporation is REG1V:xhel. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Revenio Group Corporation has its primary listing on NASDAQ OMX Helsinki. You can trade Revenio Group Corporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Revenio Group Corporation is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Revenio Group Corporation as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Revenio Group Corporation.